Ke-Shuai Dong Selected Research

Hepatocellular Carcinoma (Hepatoma)

12/2019	Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertension.
7/2017	MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke-Shuai Dong Research Topics

Disease

2	Liver Neoplasms (Liver Cancer) 01/2020 - 08/2015
2	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 07/2017
1	Carcinogenesis 11/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019
1	Portal Hypertension 12/2019
1	Thrombosis (Thrombus) 06/2018
1	Infections 07/2017
1	Hepatitis B 07/2017
1	Neoplasms (Cancer) 08/2015

Drug/Important Bio-Agent (IBA)

1	Thioredoxin Reductase 1IBA 11/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2017
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 08/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015
1	Histone Deacetylase InhibitorsIBA 08/2015

Therapy/Procedure

1	Contraindications 12/2019
1	Punctures 06/2018
1	Hepatectomy 06/2018
1	Therapeutics 06/2018
1	Thrombectomy 06/2018